Precautions and Warnings With Ipratropium and Albuterol Inhaler
There are many important precautions and warnings with ipratropium and albuterol inhaler to be aware of prior to taking the medication. Among these are the possibility that the medication can worsen breathing problems, glaucoma, and bladder problems. Precautions and warnings with ipratropium and albuterol inhaler also apply to people who are allergic to soybeans, peanuts, or soy lecithin.
The Ipratropium and Albuterol Inhaler: What Should I Tell My Healthcare Provider?
In order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer, Combivent inhalers (in their original form) will not be available after July 2013 because they contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. A new formulation, Combivent Respimat, became available starting in October 2012. People using the old Combivent inhaler will need to get a new prescription in order to switch to the new Combivent Respimat inhaler.
You should talk with your healthcare provider prior to taking the ipratropium and albuterol inhaler (Combivent®) if you have:
- An enlarged prostate (known medically as benign prostatic hyperplasia or BPH)
- A bladder problem
- High blood pressure (hypertension)
- A fast heart rate (tachycardia)
- An irregular heart rhythm (arrhythmia)
- Other types of heart disease, including congestive heart failure
- An overactive thyroid (hyperthyroidism)
- Seizures or epilepsy
- Any allergies, including allergies to food, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
Make sure to tell your healthcare provider about all of the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.